8-KEarnings & ResultsExhibits & Filings

JOHNSON & JOHNSON 8-K Report, Financial Results (Oct 13, 2020)

Filed October 13, 2020For Securities:JNJ

Summary

Johnson & Johnson (JNJ) announced its third-quarter 2020 financial results via a press release filed on October 13, 2020. The filing primarily serves to attach this press release and associated financial data, providing investors with an update on the company's performance for the quarter ended September 27, 2020. Investors should refer to the attached press release (Exhibit 99.1) and supplementary sales data (Exhibit 99.2) for detailed operational and financial information.

Key Highlights

  • 1Johnson & Johnson filed an 8-K on October 13, 2020, to report its Q3 2020 earnings and sales.
  • 2The filing's main purpose is to provide investors with the company's performance update for the quarter ending September 27, 2020.
  • 3Key financial details and operational results for the third quarter are contained within the attached press release (Exhibit 99.1).
  • 4Investors can find unaudited comparative supplementary sales data and condensed consolidated statements of earnings for Q3 2020 in Exhibit 99.2.
  • 5The event date associated with this filing is October 12, 2020, with the filing itself dated October 13, 2020.

Frequently Asked Questions

This 8-K filing serves to officially report Johnson & Johnson's third-quarter 2020 sales and earnings results to the public and the SEC. It primarily functions as a vehicle to attach the company's earnings press release and related financial exhibits.

The detailed financial results, including sales and earnings for the third quarter ended September 27, 2020, are available in Exhibit 99.1 (Press Release dated October 13, 2020) and Exhibit 99.2 (Unaudited Comparative Supplementary Sales Data and Condensed Consolidated Statement of Earnings) attached to this 8-K filing.

Based on the provided information, this 8-K filing is solely focused on reporting the Q3 2020 financial results. Any strategic announcements or significant business changes would typically be detailed in separate 8-K filings under different item numbers (e.g., Item 1.01, 8.01). Investors should review the attached press release for operational commentary.